Recital 5, Commission Regulation (EC) No 984/2009 of 21 October 2009 refusing to authorise certain…

In forcesince 21 Oct 2009

Following an application from Pierre Fabre Dermo Cosmétique submitted on 14 April 2008 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Elancyl Global Silhouette® on the regulation of body composition in people with light to moderate overweight (Question No EFSA-Q-2008-285) [The EFSA Journal (2008) 789, pp. 1-2.]. The claim proposed by the applicant was worded as follows: ‘Clinically tested as of 14 days. Your silhouette is apparently and globally redrawn, resculpted and refined at 28 days’.